BRIEF-Amgen And Allergan Receive Positive CHMP Opinion For Abp 980 By: Reuters: Company News March 23, 2018 at 08:53 AM EDT * AMGEN AND ALLERGAN RECEIVE POSITIVE CHMP OPINION FOR ABP 980 (BIOSIMILAR HERCEPTIN®) FOR THE TREATMENT OF THREE TYPES OF CANCER Read More >> Related Stocks: Allergan Plc Amgen